3. | Vaxzevria (AstraZeneca COVID‑19 vaccine) |
|
| (1) | Two doses, administered at least 24 days apart. |
|
| 14th day after the second dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
|
| (2) | Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraph (1). |
|
| 14th day after the last dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
|
4. | Covishield COVID‑19 vaccine |
|
| (1) | Two doses, administered at least 24 days apart. |
|
| 14th day after the second dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
|
| (2) | Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraph (1). |
|
| 14th day after the last dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
|
5. | Johnson & Joshson’s (J&J) Janssen COVID‑19 vaccine |
|
| | 14th day after the dose is administered. |
| 365th day (including that day) after the start of the period. |
|
6. | Sinopharm COVID‑19 vaccine |
|
| (1) | Two doses, administered at least 17 days apart. |
|
| 14th day after the second dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
|
| (2) | Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraph (1). |
|
| 14th day after the first dose is administered after recovery from the infection. |
| 365th day (including that day) after the start of the period. |
|
7. | Sinovac‑Coronavac COVID‑19 vaccine |
|
| (1) | Two doses, administered at least 13 days apart. |
|
| 14th day after the second dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
|
| (2) | Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraph (1). |
|
| 14th day after the first dose is administered after recovery from the infection. |
| 365th day (including that day) after the start of the period. |
|